Dr. Martens (LON:DOCS) Stock Price Up 17.4% - What's Next?

Shares of Dr. Martens plc (LON:DOCS - Get Free Report) traded up 17.4% during mid-day trading on Thursday . The stock traded as high as GBX 71.95 ($0.97) and last traded at GBX 70.40 ($0.95). 5,243,139 shares changed hands during mid-day trading, an increase of 136% from the average session volume of 2,224,596 shares. The stock had previously closed at GBX 59.95 ($0.81).

Wall Street Analysts Forecast Growth

Separately, Royal Bank of Canada decreased their target price on Dr. Martens from GBX 7,000 ($94.70) to GBX 6,000 ($81.17) and set a "sector perform" rating on the stock in a research report on Monday, May 19th.

Dr. Martens Trading Up 8.7%

The firm has a market cap of £795.54 million, a P/E ratio of 11.62, a P/E/G ratio of 6.40 and a beta of 0.11. The stock has a 50 day simple moving average of GBX 54.73 and a 200-day simple moving average of GBX 62.64. The company has a current ratio of 2.85, a quick ratio of 1.13 and a debt-to-equity ratio of 127.27.

Dr. Martens (LON:DOCS - Get Free Report) last posted its earnings results on Thursday, June 5th. The company reported GBX 2.40 ($0.03) earnings per share for the quarter. Dr. Martens had a net margin of 7.89% and a return on equity of 18.91%. On average, equities research analysts expect that Dr. Martens plc will post 2.5809394 EPS for the current fiscal year.

Dr. Martens Cuts Dividend

The firm also recently disclosed a dividend, which was paid on Tuesday, April 8th. Shareholders of record on Thursday, March 6th were paid a GBX 0.85 ($0.01) dividend. The ex-dividend date of this dividend was Thursday, March 6th. This represents a dividend yield of 1.47%. Dr. Martens's payout ratio is currently 42.53%.

Insider Transactions at Dr. Martens

In related news, insider Giles Wilson purchased 32,640 shares of the company's stock in a transaction that occurred on Tuesday, March 25th. The stock was bought at an average price of GBX 54 ($0.73) per share, for a total transaction of £17,625.60 ($23,844.16). Insiders have acquired a total of 33,206 shares of company stock worth $1,792,771 in the last three months. Insiders own 4.36% of the company's stock.

Dr. Martens Company Profile

Dr. Martens is an iconic British brand founded in 1960 in Northamptonshire. Originally produced for workers looking for tough, durable boots, the brand was quickly adopted by diverse youth subcultures and associated musical movements. Dr. Martens have since transcended their working-class roots while still celebrating their proud heritage and, six decades later, “Docs” or “DMs” are worn by people around the world who use them as a symbol of empowerment and their own individual attitude. The Company successfully listed on the main market of the London Stock Exchange on 29 January 2021 (DOCS.L) and is a constituent of the FTSE 250 index.